Polymeric and Hybrid Nanoparticles
Polymeric and hybrid nanoparticles offer powerful advantages for drug delivery, enabling controlled release, targeted delivery, and improved bioavailability of a wide range of therapeutics. Our consulting services support the design, development, and optimization of polymer-based and hybrid nanoparticle systems for pharmaceutical and biotech applications.
With deep expertise in formulation science, material selection, and nanoparticle engineering, we help innovators develop advanced delivery systems tailored to the physicochemical and therapeutic needs of their APIs—including small molecules, biologics, nucleic acids, and peptides.
Our Polymeric & Hybrid Nanoparticle Services
1. Custom Formulation Design
We work with clients to create tailored nanoparticle systems optimized for drug payload, release kinetics, stability, and targeting.
Includes:
- Selection of biocompatible and biodegradable polymers (e.g., PLGA, PEG, PCL)
- Block copolymer and amphiphilic hybrid design
- Encapsulation strategies for hydrophobic, hydrophilic, or amphiphilic drugs
- pH-responsive, stimuli-responsive, and ligand-targeted systems
2. Process Development & Scale-Up
We translate research formulations into scalable, GMP-compatible processes for clinical and commercial readiness.
Includes:
- Solvent evaporation, nanoprecipitation, and emulsification techniques
- Continuous and batch processing optimization
- Scale-up feasibility and critical process parameter (CPP) identification
- Filtration, lyophilization, and sterilization compatibility
3. Characterization & Analytical Support
Thorough physicochemical and functional characterization ensures performance, quality, and regulatory compliance.
Includes:
- Particle size, morphology, and zeta potential analysis
- Encapsulation efficiency and release profile studies
- Stability testing and accelerated degradation assays
- Surface functionalization and ligand density measurement
4. Therapeutic Applications & Targeting Strategies
We support clients in applying polymeric and hybrid nanoparticles across diverse indications.
Use cases include:
- Oncology and targeted chemotherapeutics
- mRNA and siRNA delivery
- Protein and peptide stabilization
- Localized, extended-release systems
- Vaccine and adjuvant delivery
Why Work With Us
- Advanced expertise: 12+ years developing novel drug delivery platforms, including polymeric and hybrid nanomedicines
- Translational focus: End-to-end support from formulation through preclinical development, scale-up, and GMP readiness
- Regulatory insight: Methods and materials aligned with global regulatory standards
- Customization-first: Every system is engineered for your specific therapeutic and commercial goals
Deliver Smarter. Engineer with Precision.
If you're exploring polymeric or hybrid nanoparticle technologies, we offer the technical expertise and strategic insight to accelerate your innovation.
đź“§ Contact us today to schedule a consultation and start developing your next-generation nanoparticle platform.